← Open Payments lookup

CRISTINA BARNES: Open Payments

NPI 1548934219 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,476 in 104 payments from 16 companies in 2025. Trend: 2023 $2,704 · 2024 $2,084 · 2025 $3,476

Food & beverage: $2,392Consulting: $1,050Education: $34
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.8$1,161
AstraZeneca Pharmaceuticals LP24$671
GENZYME CORPORATION25$650
GlaxoSmithKline, LLC.11$181
Grifols USA, LLC7$166
Novartis Pharmaceuticals Corporation5$162
CSL Behring6$139
Takeda Pharmaceuticals U.S.A., Inc.4$73
PFIZER INC.3$52
Galderma Laboratories, L.P.3$47

Products named: DUPIXENT, FASENRA, Xembify, AIRSUPRA, NUCALA, Hizentra, AYVAKIT, TEZSPIRE.

Industry payments across OK — which companies pay providers there.